Syros Pharmaceuticals, Inc.

LSE:0LC7 Stock Report

Market Cap: US$6.7m

Syros Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0LC7 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Nov 24SellUS$10,321Gerald QuirkIndividual46,657US$0.22
18 Nov 24SellUS$28,980Jason HaasIndividual137,803US$0.21
18 Nov 24SellUS$2,382David RothIndividual12,099US$0.20
18 Nov 24SellUS$7,949Kristin StephensIndividual36,133US$0.22
18 Nov 24SellUS$26,932Conley CheeIndividual134,797US$0.20
12 Sep 24BuyUS$161,240Jason HaasIndividual100,000US$1.68
11 Sep 24BuyUS$160,680Conley CheeIndividual100,000US$1.71
21 Dec 23BuyUS$3,999,998Samsara BioCapital LLCCompany904,977US$4.42

Insider Trading Volume

Insider Buying: 0LC7 insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0LC7?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders336,7901.26%
General Public4,985,92718.6%
Hedge Funds6,401,85323.9%
VC/PE Firms7,123,95026.5%
Institutions7,983,93729.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.4%.

Top Shareholders

Top 25 shareholders own 78.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
Avidity Partners Management, L.P.
2,857,573US$717.0k70.8%0.05%
10.3%
Bain Capital Life Sciences Investors, LLC
2,750,151US$690.0k0.01%0.08%
9.64%
Artal Group S.A.
2,587,372US$649.2k3.29%0.02%
7.72%
Adage Capital Management, L.P.
2,071,914US$519.8k0%no data
6.66%
Samsara BioCapital LLC
1,786,427US$448.2k0%0.08%
5.49%
Point72 Asset Management, L.P.
1,472,366US$369.4k-0.22%no data
4.82%
Flagship Pioneering, Inc
1,293,849US$324.6k0%0.1%
3.55%
The Vanguard Group, Inc.
953,313US$239.2k-1.54%no data
3.09%
Deep Track Capital, LP
828,485US$207.9k0%0.01%
2.44%
Opaleye Management Inc.
654,943US$164.3k-24.3%0.03%
1.98%
Cowen Inc,Private Banking and Investment Banking Investments
531,914US$133.5k0%no data
1.92%
CHI Advisors LLC
515,855US$129.4k51.3%0.06%
1.34%
UBS O'Connor LLC
359,305US$90.1k29.2%0.01%
1.17%
ExodusPoint Capital Management, LP
313,004US$78.5k18.7%no data
1.11%
Exome Asset Management LLC
298,575US$74.9k87.6%0.06%
0.97%
BlackRock, Inc.
261,579US$65.6k0.92%no data
0.94%
Omega Fund Management, LLC
251,270US$63.0k0%0.04%
0.8%
Invus Financial Advisors, LLC
214,159US$53.7k0%0.06%
0.76%
Geode Capital Management, LLC
204,695US$51.4k-9.47%no data
0.66%
Nancy Simonian
175,783US$44.1k29.6%no data
0.6%
Marshall Wace LLP
160,390US$40.2k0%no data
0.44%
Perceptive Advisors LLC
116,754US$29.3k0%no data
0.36%
Renaissance Technologies LLC
96,435US$24.2k-17.9%no data
0.33%
Prelude Capital Management, LLC
89,097US$22.4k121%no data
0.32%
Walleye Capital LLC
86,641US$21.7k-69.7%no data